Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Magnus Medical announced it raised $23.7 Million in an initial filing from an offering of $77 Million
PRIVATEMay 12, 2025•over 1 year ago
Amount Raised
$23.7 Million
Round Type
Venture - Series Unknown
BurlingameHealth Care
Company Information
Company
Magnus Medical
Location
Burlingame, California, United States
About
Magnus Medical is a privately held medical device company driven to transform lives by restoring mental health. The company is a developer of brain stimulation technology for the treatment of neuropsychiatric disorders. Its first product is the SAINT™ Neuromodulation System, granted Breakthrough Device Designation and 510(k) clearance by the U.S. Food & Drug Administration (FDA) in September 2022 for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.
Don't miss Magnus Medical's next move
Get an email the moment Magnus Medical raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Predictive Intelligence
Strategic
ML-powered predictions for Magnus Medical's next move